Telmisartan
502.373
Approved small_molecule completed
Quick answer
Telmisartan for Cardiovascular Diseases is a Approved program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Cardiovascular Diseases
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed